Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE In the patient diagnosed with aCML in bone marrow study, two CSF3R mutations, (T618I and Y779*) a SETBP1 mutation (G870S) and an U2AF1 mutation (Q157P), were identified by high-coverage next-generation sequencing. 31692115 2020
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE Blast content of the bone marrow revealed an inverse correlation with the mutation status of SETBP1 in aCML and TET2 in CMML, respectively. 30635983 2019
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE SETBP1 variants occur as somatic mutations in several hematological malignancies such as atypical chronic myeloid leukemia and as de novo germline mutations in the Schinzel-Giedion syndrome. 29875417 2018
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE Despite the recent identification of recurrent SETBP1 mutations in atypical chronic myeloid leukemia (aCML), a complete description of the somatic lesions responsible for the onset of this disorder is still lacking. 25343957 2015
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE Recurrent somatic SET-binding protein 1 (SETBP1) and splicing pathway gene mutations have recently been found in atypical chronic myeloid leukemia and other hematologic malignancies. 25553291 2015
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE SETBP1 mutations may be associated with an adverse prognosis, so their detection would help in the diagnosis of aCML and the determination of a patient's prognosis. 26017341 2015
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 Biomarker disease CTD_human In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases. 23222956 2013
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE Here we report whole-exome sequencing of individuals with various myeloid malignancies and identify recurrent somatic mutations in SETBP1, consistent with a recent report on atypical chronic myeloid leukemia (aCML). 23832012 2013
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 GeneticVariation disease BEFREE In particular, there was a high frequency of SETBP1 mutation in aCML (19/60; 31.7%) and MDS/MPN unclassifiable (MDS/MPN, U; 20/240; 9.3%). 23628959 2013
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 Biomarker disease BEFREE In summary, mutated SETBP1 represents a newly discovered oncogene present in aCML and closely related diseases. 23222956 2013
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
0.590 CausalMutation disease CGI